Iodide

Iodide

SCHEMBL386911

CC(C)(C)OC(=O)n1cccc1C[P+](c1ccccc1)(c1ccccc1)c1ccccc1.[I-]

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHRM1CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNG

The experimentally established mechanism targets of Iodide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.39
HSP90AA1 P07900 1/20 0.38
HSP90AB1 P08238 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.36
ABCB1 P08183 1/20 0.35
PIK3R1 P27986 1/20 0.35
PIK3CA P42336 1/20 0.35
GPR119 Q8TDV5 1/20 0.34
TNK2 Q07912 1/20 0.34
BUB1 O43683 1/20 0.34
KDM4E B2RXH2 1/20 0.34
PKM P14618 1/20 0.34
TSHR P16473 2/20 0.33
ATM Q13315 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C19 P33261 1/20 0.33
ALOX15 P16050 1/20 0.33
ACE P12821 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2628927 0.77 HSP90AA1 (0.44) BCHEHSP90AA1HSP90AB1L3MBTL1ABCB1
SCHEMBL445392 0.77 HSP90AA1 (0.44) BCHEHSP90AA1HSP90AB1L3MBTL1ABCB1
SCHEMBL445394 0.77 HSP90AA1 (0.44) BCHEHSP90AA1HSP90AB1L3MBTL1ABCB1
SCHEMBL19974442 0.76 HSP90AA1 (0.49) BCHEHSP90AA1HSP90AB1L3MBTL1ABCB1
SCHEMBL14949338 0.75 HSP90AA1 (0.42) BCHEHSP90AA1HSP90AB1L3MBTL1ABCB1
SCHEMBL23303726 0.73 HSP90AA1 (0.41) BCHEHSP90AA1HSP90AB1L3MBTL1ABCB1
SCHEMBL8293842 0.73 HSP90AA1 (0.42) BCHEHSP90AA1HSP90AB1L3MBTL1ABCB1
SCHEMBL386910 0.73 L3MBTL1 (0.40) BCHEHSP90AA1HSP90AB1L3MBTL1ABCB1
SCHEMBL5156671 0.73 JAK2 (0.36) BCHEHSP90AA1HSP90AB1ATMACE
SCHEMBL28190821 0.72 HSP90AA1 (0.39) BCHEHSP90AA1HSP90AB1L3MBTL1ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101650-B2 Method for treating a immunology-related disease DAIICHI SANKYO COMPANY, LIMITED (JP) 2012-01-24 US disclosed
US-8067396-B2 Amino alcohol compounds or phosphonic acid derivatives thereof SANKYO COMPANY, LIMITED (JP) 2011-11-29 US disclosed
US-20100035842-A1 Amino alcohol compounds or phosphonic acid derivatives thereof SANKYO COMPANY, LIMITED (JP) 2010-02-11 US disclosed
US-20090326038-A1 Method for treating a immunology-related disease SANKYO COMPANY, LIMITED (JP) 2009-12-31 US disclosed
US-7638551-B2 Amino alcohol compounds or phosphonic acid derivatives thereof SANKYO COMPANY, LIMITED (JP) 2009-12-29 US disclosed
EP-1471054-B1 AMINO ALCOHOL DERIVATIVE OR PHOSPHONIC ACID DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING THESE DAIICHI SANKYO CO LTD (JP) 2009-07-01 EP disclosed
US-20070142335-A1 Amino alcohol compounds or phosphonic acid derivatives thereof SANKYO COMPANY, LIMITED (JP) 2007-06-21 US disclosed
US-20070105933-A1 Amino alcohol compounds SANKYO COMPANY, LIMITED (JP) 2007-05-10 US disclosed
US-7199150-B2 Amino alcohol compounds SANKYO COMPANY, LIMITED (JP) 2007-04-03 US disclosed
US-20050043386-A1 Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these SANKYO COMPANY, LIMITED (JP) 2005-02-24 US disclosed
EP-1471054-A1 AMINO ALCOHOL DERIVATIVE OR PHOSPHONIC ACID DERIVATIVE AND MEDICINAL COMPOSITION CONTAINING THESE Sankyo Company, Limited (JP) 2004-10-27 EP disclosed
EP-1149092-B1 4- AND 5-ALKYNYLOXINDOLES AND 4- AND 5-ALKENYLOXINDOLES HOFFMANN LA ROCHE (CH) 2003-10-29 EP disclosed
US-6313310-B1 JUN N-TERMINAL KINASE (JNK) ENZYME INHIBITORS; ANTIINFLAMMATORY AGENTS; RHEUMATIC ARTHRITIS AND NEURO-DEGENERATIVE DISEASE TREATMENT HOFFMANN-LA ROCHE INC. 2001-11-06 US disclosed
EP-1149092-A2 4- AND 5-ALKYNYLOXINDOLES AND 4- AND 5-ALKENYLOXINDOLES F. HOFFMANN-LA ROCHE AG (CH) 2001-10-31 EP disclosed
WO-2000035906-A2 4- AND 5-ALKYNYLOXINDOLES AND 4- AND 5-ALKENYLOXINDOLES F. HOFFMANN-LA ROCHE AG (CH) 2000-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050043386-A1 Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these PHOSPHO1, CD4, FCGRT BCHE 2350/4885HSP90AA1 2575/4885HSP90AB1 3092/4885
US-20090326038-A1 Method for treating a immunology-related disease C3AR1, HRH3, HRH2 BCHE 359/4885HSP90AA1 3297/4885HSP90AB1 3335/4885
US-20070105933-A1 Amino alcohol compounds ADH1C, C9, SSB BCHE 2962/4885HSP90AA1 3581/4885HSP90AB1 4135/4885
US-20070142335-A1 Amino alcohol compounds or phosphonic acid derivatives thereof HRH3, C3AR1, HRH4 BCHE 2674/4885HSP90AA1 2844/4885HSP90AB1 3430/4885
US-20100035842-A1 Amino alcohol compounds or phosphonic acid derivatives thereof PHOSPHO1, ADH1C, ADH1A BCHE 2253/4885HSP90AA1 3481/4885HSP90AB1 4235/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.